Ultrasound-Guided Core Needle Biopsy to Stage Urothelial Carcinoma of the Bladder (US UCB)

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
Mayo Clinic
Study ID
NCT07029256
Status
Recruiting
Apply to this trial

Conditions

  • Bladder Urothelial Carcinoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Non-Interventional Study — OTHER
    Non-interventional study

Study Details

This study is being done to test the feasibility and accuracy of using an ultrasound-guided core needle biopsy technique as a potential tool for staging urothelial carcinoma of the bladder (UCB).

Key Dates

Start date
Jul 26, 2024
Status verified
Jun 2026
Primary completion
Jul 30, 2030
Completion
Jul 30, 2030

Study Design

Enrollment
100 participants (estimated)

Arms

  • Arm: Observational
    Patients undergo standard of care radical cystectomy and residual tissues collected undergo US core needle biopsy. Additionally, patients have their medical records reviewed on study.

Primary Outcome Measure

Concordance between US and core needle biopsy stage and final surgical specimen pathologic stage [ Time Frame: Baseline (after completion of bladder surgery) ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905
Hosanna Yeadon, BA
[email protected]
507-538-5019
Clinical Trials Referral Office
[email protected]
855-776-0015
Vidit Sharma, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

By research site
Mayo Clinic in Rochester· Rochester, MN

Related Studies